Mechanisms of inflammation induced tissue injury in multiple sclerosis

Journal of the Neurological Sciences

Volumn 274, Issue 1-2, 2008, Pages 45-47

  Lassmann, Hans ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Auto antibodies; Cytotoxic T cells; Demyelination; Innate immunity; Multiple sclerosis

Indexed keywords

AUTOANTIBODY;

ADAPTIVE IMMUNITY; ARTICLE; AXONAL INJURY; CYTOTOXIC T LYMPHOCYTE; DEMYELINATION; HUMAN; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; AXONS; BRAIN; HUMANS; INFLAMMATION; MULTIPLE SCLEROSIS;

EID: 53049085062     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.04.003     Document Type: Article

References (39)

1. Hendriks J.J., Teunissen C.E., de Vries H.E., and Dijkstra C.D. Macrophages and neurodegeneration. Brain Res Brain Res Rev 48 (2006) 185-195
2. Huseby E.S., Liggitt D., Brabb T., Schnabel B., Ohlen C., and Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med 194 (2001) 669-676
3. Cabarrocas J., Bauer J., Piaggio E., Liblau R., and Lassmann H. Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes. Eur-J-Immunol 33 5 (2003) 1174-1182
4. Linington C., Bradl M., Lassmann H., Brunner C., and Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Amer J Pathol 130 (1988) 443-454
5. Felts P.A., Woolston A.M., Fernando H.B., Asquith S., Gregson N.A., Mizzi O.J., et al. Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide. Brain 128 (2005) 1649-1666
6. Kutzelnigg A., Lucchinetti C.F., Stadelmann C., Bruck W., Rauschka H., Bergmann M., et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128 Pt 11 (2005) 2705-2712
7. Hochmeister S., Grundtner P., Bauer J., Engelhardt B., Lyck R., Gordon G., et al. Dysferlin is a new marker for leaky blood vessels in multiple sclerosis. J Neuropath Exp Neurol 65 (2006) 855-865
8. Lucchinetti C., Brück W., Parisi J., Scheithauer B., Rodriguez M., and Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47 (2000) 707-717
9. Prineas J.W., Kwon E.E., Cho E.S., Sharer L.R., Barnett M.H., Oleszak E.L., et al. Immunopathology of secondary-progressive multiple sclerosis. Ann Neurol 50 (2001) 646-657
10. Kidd T., Barkhof F., McConnell R., Algra P.R., Allen I.V., and Revesz T. Cortical lesions in multiple sclerosis. Brain 122 (1999) 17-26
11. Peterson J.W., Bo L., Mork S., Chang A., and Trapp B.D. Transsected neurites, apoptotic neurons and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 50 (2001) 389-400
12. Babbe H., Roers A., Waisman A., Lassmann H., Goebels N., Hohlfeld R., et al. Clonal expansion of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 192 (2000) 393-404
13. Skulina C., Schmidt S., Dornmair K., Babbe H., Roers A., Rajewsky K., et al. Multiple sclerosis: brain infiltrating CD8+ T-cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc. Natl Acad Sci (USA) 101 (2004) 2428-2433
14. Junker A., Ivanidze J., Malotka J., Eiglmeier I., Lassmann H., Wekerle H., et al. Multiple sclerosis: T-cell receptor expression in distinct brain regions. Brain 130 (2007) 2789-2799
15. Hoeftberger R., Aboul-Enein F., Brueck W., Lucchinetti C., Rodriguez M., Schmidbauer M., et al. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain-Pathol 14 1 (2004) 43-55
16. Zhang Y.C., Li S., Rivera V.M., Hong J., Robinson R.R., Breitbach W.T., et al. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis. J Immunol 172 (2004) 5120-5127
17. Seitz S., Schneider C.K., Malotka J., Nong X., Engel A.G., Wekerle H., et al. Reconstitution of paired T cell receptor alpha- and beta-chains from microdissected single cells of human inflammatory tissues. Proc Natl Acad Sci (USA) 103 (2006) 12057-12062
18. Berger T., Rubner P., Schautzer F., Egg R., Ulmer H., Mayringer I., et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after the first demyelinating event. New Engl J Med 349 (2003) 139-145
19. Kanter J.L., Narayana S., Ho P.P., Catz I., Warren K.G., Sobel R.A., et al. Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med 12 (2006) 138-143
20. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., and Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202 (2005) 473-477
21. Lennon V.A., Wingerchuk D.N., Kryzer T.J., Pittock S.J., Lucchinetti C.F., Fujihara K., et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364 (2004) 2106-2112
22. Lucchinetti C.F., Mandler R.N., McGavern D., Bruck W., Gleich G., Ransohoff R.M., et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125 (2002) 1450-1461
23. Roemer S.F., Parisi J.E., Lennon V.A., Bennaroch E.E., Lassmann H., Brück W., et al. Pattern-specific loss of aquaporin 4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130 (2007) 1194-1205
24. Zhou D., Srivastava R., Nessler S., Grummel V., Sommer N., Brück W., et al. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc Natl Acad Sci (USA) 103 (2006) 19057-19062
25. Mathey E.K., Derfuss T., Storch M.K., Williams K.R., Hales K., Wooley D.R., et al. Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med 204 (2007) 2363-2372
26. Barnett M.H., and Prineas J.W. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55 (2004) 458-468
27. Marik C., Felts P., Bauer J., Lassmann H., and Smith K.J. Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?. Brain 130 (2007) 2800-2815
28. Adams R.A., Bauer J., Flick M.J., Sikoski S.L., Nuriel T., Lassmann H., et al. The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J Exp Med 204 (2007) 571-582
29. Diestel A., Atkas O., Hackel D., Hake I., Meier S., Raine C.S., et al. Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damage. J Exp Med 198 (2003) 1729-1740
30. Anderson A.C., Anderson D.E., Bregoli L., Hastings W.D., Kassam N., Lei C., et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318 (2007) 1141-1143
31. Aboul-Enein F., Rauschka H., Kornek B., Stadelmann C., Stefferl A., Bruck W., et al. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Exp Neurol. 62 1 (2003) 25-33
32. Graumann U., Reynolds R., Steck A.J., and Schaeren-Wiemers N. Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol 13 (2003) 554-573
33. Evangelou N., Konz D., Esiri M.M., Smith S., Palace J., and Matthews P.M. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 124 (2001) 1813-1820
34. Stys P.K. General mechanisms of axonal damage and its prevention. J Neurol Sci 133 (2005) 3-13
35. Dutta R., McDonough J., Yin X., Peterson J., Chang A., Torres T., et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis. Ann Neurol 59 (2006) 478-489
36. Smith K.J. Sodium channels and multiple sclerosis: roles in symptom production, damage and therapy. Brain Pathol 17 (2007) 230-242
37. Bechtold D.A., Miller S.J., Dawson A.C., Sun Y., Kapoor R., Berry D., et al. Axonal protection achieved in a model of multiple sclerosis using lamotrigine. J Neurol 253 (2006) 1542-1551
38. Black J.A., Liu S., Hains B.C., Saab C.Y., and Waxman S.G. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE. Brain 129 (2006) 3147-3149
39. Forte M., Gold B.G., Marracci G., Chaudhary P., Basso E., Johnsen D., et al. Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Proc Natl Acad Sci (USA) 104 (2007) 7558-7563